Description
The FDA approved the use of prasugrel for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI.
$121.00 – $123.00
The FDA approved the use of prasugrel for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI.
Only logged in customers who have purchased this product may leave a review.
Kayden (verified owner) –
The product is firmly packed.
Angel (verified owner) –
The product is firmly packed.
Camden (verified owner) –
Very fast delivery.